ATMP |
Advanced therapy medicinal product |
TMJ-OA |
Temporomandibular joint osteoarthritis |
TMJ |
Temporomandibular joint |
TMD |
Temporomandibular disorder |
ABS |
Treatment group 1: AB Serum |
HA |
Treatment group 2: Hyaluronic acid |
STx. |
Treatment group 3: Mesenchymal stromal cells (Oxacells HP) |
HA + STx. |
Treatment group 4: Hyaluronic acid + Mesenchymal stromal cells (Oxacells HP) |
TMJD |
Temporomandibular joint disorders |
RDC |
Research Diagnostic Criteria |
TENS |
Transcutaneous electrical nerve stimulation |
NSAID |
Non-steroidal anti-inflammatory drugs |
PRP |
Platelet Rich Plasma |
MSC |
Mesenchymal stromal cells |
ESC |
Embryonic stromal cells |
ISCT |
International Society for Cellular Therapy |
ASC |
Adipose-derived stromal cells |
SVF |
Stromal vascular fraction |
BEI |
Back-scattered electron imaging |
AC |
Articular cartilage |
SMZ |
Subchondral mineralized zone |
GAG |
Glycosaminoglycans |
ADSC |
Adipose tissue-derived stromal cells |
PDLSC |
Periodontal ligament stromal cells |
SCAP |
Stromal cells from apical papilla |
DFPC |
Dental follicle progenitor cells |
DPSC |
Dental pulp stromal cells |
MPC |
Mesenchymal progenitor cells |
hMSC |
Human mesenchymal stromal cells |
ACLT |
Anterior cruciate ligament transaction |
PBS |
Phosphate-buffered saline |
PMMA |
Polymethylmethacrylate |